Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma

被引:11
作者
Hou, Xiao-Yang [1 ]
Jiang, Guan [1 ]
Yang, Chun-Sheng [2 ]
Tang, Jian-Qin [1 ]
Wei, Zhi-Ping [1 ]
Liu, Yan-Qun [1 ]
机构
[1] Xuzhou Med Coll, Affiliated Hosp, Dept Dermatol, Xuzhou 221002, Jiangsu, Peoples R China
[2] Xuzhou Med Coll, Affiliated Huaian Hosp, Dept Dermatol, Huaian 223002, Peoples R China
基金
中国国家自然科学基金;
关键词
Active targeting; EPR effect; gene therapy; hepatocellular carcinoma (HCC); nanotechnology; passive targeting; clinical trials; IRON-OXIDE NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; DRUG-DELIVERY; CANCER-CELLS; IN-VITRO; GOLD NANOPARTICLES; LUNG-CANCER; MULTIDRUG-RESISTANCE; COMPUTED-TOMOGRAPHY; FOLATE RECEPTOR;
D O I
10.2174/1574892811666160309121035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. However, the inherent limitations of traditional surgery and insensitivity to radiation and chemotherapy result in failing treatment and poor prognosis. In recent years, the development and advances of nanotechnology has brought new hope for the diagnosis and treatment of HCC. This article reviews the development of nanoparticles used for cancer detection, diagnosis and treatment due to their large specific surface area and unique optical, electronic and magnetic properties. Moreover, studies have shown that after intended surface modification, nano-carriers can achieve active targeting effect, which improves the efficiency of chemotherapeutic drugs and decreases their side effects. In this review, we provide an overview of these studies results, patents about novel nano-materials and conclude with a discussion about future development.
引用
收藏
页码:322 / 331
页数:10
相关论文
共 130 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]   Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species [J].
Akhtar, Mohd Javed ;
Ahamed, Maqusood ;
Kumar, Sudhir ;
Khan, M. A. Majeed ;
Ahmad, Javed ;
Alrokayan, Salman A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 :845-857
[3]   Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions [J].
Alkilany, Alaaldin M. ;
Thompson, Lucas B. ;
Boulos, Stefano P. ;
Sisco, Patrick N. ;
Murphy, Catherine J. .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (02) :190-199
[4]  
[Anonymous], J DRUG TARGET
[5]   Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin [J].
Arabi, Leila ;
Badiee, Ali ;
Mosaffa, Fatemeh ;
Jaafari, Mahmoud Reza .
JOURNAL OF CONTROLLED RELEASE, 2015, 220 :275-286
[6]   Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle [J].
Arvizo, Rochelle R. ;
Saha, Sounik ;
Wang, Enfeng ;
Robertson, J. David ;
Bhattacharya, Resham ;
Mukherjee, Priyabrata .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (17) :6700-6705
[7]   Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge [J].
Arvizo, Rochelle R. ;
Rana, Subinoy ;
Miranda, Oscar R. ;
Bhattacharya, Resham ;
Rotello, Vincent M. ;
Mukherjee, Priyabrata .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (05) :580-587
[8]   Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? [J].
Asghar, Uzma ;
Meyer, Tim .
JOURNAL OF HEPATOLOGY, 2012, 56 (03) :686-695
[9]   Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer [J].
Bai, Fan ;
Wang, Chao ;
Lu, Qin ;
Zhao, Mei ;
Ban, Fu-Qiang ;
Yu, De-Hong ;
Guan, Ying-Yun ;
Luan, Xin ;
Liu, Ya-Rong ;
Chen, Hong-Zhuan ;
Fang, Chao .
BIOMATERIALS, 2013, 34 (26) :6163-6174
[10]  
Bamrungsap S, 2012, NANOMEDICINE-UK, V7, P1253, DOI [10.2217/nnm.12.87, 10.2217/NNM.12.87]